New Psychoactive Substances (NPS) in Pooled Urine and Wastewater:

Slides:



Advertisements
Similar presentations
Opinion of the Scientific Committee regarding the scientific aspects of the risk assessment exercise R. Sedefov & A. Gallegos, 33th Meeting of the Scientific.
Advertisements

Dr Paul Dargan & Dr David Wood Consultant Clinical Toxicologists Guy’s and St Thomas’ NHS Foundation Trust London, UK Monitoring Drug Emergencies How and.
1 New drugs coming our way - - what are they and how do we detect them? Leslie A King UK Focal Point on Drugs EMCDDA Conference: Identifying Europe’s information.
European Early Warning System Charlotte Davies. European Early Warning System Adopted in May 2005, the Council Decision 2005/387/JHA on the information.
Overview of Drug Testing Process
Designer Drugs – What Drug Court Practitioners Need to Know
Designer Drugs – What You Need to Know The Fundamentals By: Paul L. Cary Toxicology Laboratory University of Missouri.
History 2010 Law enforcement first started hearing about “Synthetic cocaine” Not actually cocaine, but Mephedrone At that time, very little was known Illegal.
Seth Cooper Jason Kennedy Kansas City Police Crimelab Synthetic Cannabinoids and Bath Salts.
Novel Psychoactive Substances
Annual report 2010: the state of the drugs problem in Europe.
Clinical Experience of Novel Psychoactive Substances Dr Richard Stevenson.
All Island Tourism Statistics Liaison Group CSO releases – HTS, Overseas Travel and PCI Patsy King 24 June 2014.
Department of Meteorology Maldives Implementation of Male’ Declaration on Control and Prevention of Air Pollution and its Likely Transboundary Effects.
A look into the Expert Panels Review By Leigh
Broward Quick Check September 2012 Drug Abuse Patterns and Trends Update James N. Hall, Epidemiologist Center for Applied Research on Substance Use and.
WORD JUMBLE. Months of the year Word in jumbled form e r r f b u y a Word in jumbled form e r r f b u y a february Click for the answer Next Question.
OVERSEAS VISITS, QUARTER FACTSHEET LONDON: OVERSEAS VISITS, NIGHTS & SPEND, Q Q2 (April–June) visits, at 4.54 million, were up by 10.4% on.
Screens and tests for NPS Dr Paul Smith Consultant Clinical Scientist and Forensic Toxicologist
Hitting a moving target Managing NPS harms Dr Owen Bowden-Jones Addiction Psychiatrist Imperial College London.
Cannabinoid Concentrations Detected in Fatal Road Traffic Collision Victims Compared with a Population of Other Post Mortem Cases R. Andrews, K.G. Murphy,
USAGE OF DRUGS IN EUROPE LSD CANNABIS. ALL ADULTS (15-64) USAGE OF LSD IN EUROPE All adults (15-64) Usage of LSD in Europe datesample sizemalefemaletotal.
TEDI TEDI Trans European Drug Information Mireia Ventura – Energy control Barcelona Alexander Bücheli – City of Zurich youth counseling Streetwork.
New Psychoactive Substances Presented by Barry James Forensic Scientist (Drugs) 15 th September 2015.
NPS injecting harms and harm reduction. Psychoactive Substances Health Workshop Friday 4 th March 2016 Emma Hamilton A national resource of expertise on.
NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.
Annual report 2012: the state of the drugs problem in Europe Name, date.
Cameron Francis Social Worker. Firstly, what is Dovetail? Dovetail provides clinical advice and professional support to workers, services and communities.
World Drug Report 2016 Cocaine and heroin prices in Western Europe* and in the USA *Calculations for Western Europe based on data from Austria,
USD billion
NEW PSYCHOACTIVE SUBSTANCES (NPS) AND HARM REDUCTION
Florida Drug Trends Update November 2015
Countries and Capitals of Western Europe
Identification and Assessment of New Psychoactive Substances: A European Network Identification and assessment of new psychoactive substances: a European.
DR. Fernando Caudevilla Energy control (ABD)
World Drug Report 2011.
Development and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay. Annelies Cannaert, Jolien Storme, Florian.
Mission Briefing on the World Drug Report 2012
THE GERMAN NEW PSYCHOACTIVE SUBSTANCE LAW (NPSG): PERCEIVED AND EXPECTED OUTCOMES IN THE FIRST STAGE OF IMPLEMENTATION. Tessa-Virginia Hannemann.
Professor Paul I Dargan
High risk drug use and NPS in Europe
Dictation practice 2nd Form Ms. Micaela-Ms. Verónica.
The EU Early Warning System: 20 years of monitoring New Psychoactive Substances in Europe Rachel Christie, PhD 24 October 2017, Lisbon Lisbon Addictions.
Rachel Sutherland, Monica Barratt, Lucinda Burns and Raimondo Bruno
Detection of new psychoactive substances (NPS) use across Europe
The analysis of illicit drugs
New Psychoactive Substances (NPS) in Deep Web Marketplaces (DWM):
WS 3 Monitoring extent and patterns of use of NPS
Ettore Zuccato Plenary meeting 3, Castellon 29th March 2017
Comparison of data from WBE with other sources
Number of visitors to the library.
New Psychoactive Substances in Portugal
Drug use among MSM (overview with focus on chemsex)
Ettore Zuccato Plenary meeting 4, Milan 1-2 February 2018
Workstream 1: Identification and characterization of NPS
City statistics – state of play of data collection
MY FUNDAY.
2300 (11PM) September 21 Blue line is meridian..
Designer drugs of abuse: The science behind the headlines
F. Tagliaro, University of Verona, Italy in collaboration with
World Populations Why is the population uneven across the globe?
SEPTEMBER ½ Day Unit PLC
January 2015 Sunday Monday Tuesday Wednesday Thursday Friday Saturday
WELCOME.
City Council Business Meeting
WEST EUROPE MAP REVIEW.
Write the date in English
Skopje, 21 November 2017, General Population Survey results– launch
Монголын даатгалын зах зээлийн бодлогын асуудлууд
Risk Reduction on New Drugs,
Presentation transcript:

New Psychoactive Substances (NPS) in Pooled Urine and Wastewater: A Review Iria González Mariño 29th February 2016

Early Warning Advisory on NPS. UNODC 2015 NPS - Classification Early Warning Advisory on NPS. UNODC 2015

NPS – Number NPS in Europe. An update from the EU Early Warning System. EMCDDA 2015

NPS – Seizures NPS in Europe. An update from the EU Early Warning System. EMCDDA 2015

Urine from individual consumers Pooled urine from portable urinals NPS – Alternative monitoring Urine from individual consumers Pooled urine from portable urinals Wastewater

     NPS – Alternative monitoring Urine from individual consumers Not practical at population/subpopulation levels Pooled urine from portable urinals Limited to subpopulations (although, actually, the part of a population most likely to contribute to the consumpion of NPS in a specific location) Only published studies from UK   Wastewater Extensible to “regional” populations Limited usefulness in the case of NPS due to limited information on their pharmacokinetics and metabolism; low prevalence of consumption -> low concentrations in wastewater; lack of information on their stability  

3-trifluoromethylphenylpiperazine (TFMPP) NPS in Pooled Urine Synth. cathinones Synth. cannabinoids Phenethylamines Piperazines Ketamine analogs 1 portable urinal at a large nightclub in South London 4 pooled samples at different times over one weekend in July 2011 NPS C median (ng/mL) Metabolites Mephedrone 2965.1 + 3-trifluoromethylphenylpiperazine (TFMPP) 123.7 2-aminoindane (2-AI) 27.2

Frequency of detection Methylhexanamine (DMAA) Methiopropamine (MPA) NPS in Pooled Urine Synth. cathinones Synth. cannabinoids Phenethylamines Piperazines Ketamine analogs 12 portable urinals distributted in Westminster (Central London) 1 sample per urinal after a 12-h period on a Saturday night in March 2012 NPS Frequency of detection (n. of urinals) Metabolites Hordenine 12 Methylhexanamine (DMAA) 9 Mephedrone 6 Methiopropamine (MPA) 2 + Methoxetamine (MXE) 1

NPS in Pooled Urine Synth. cathinones Synth. cannabinoids Phenethylamines Piperazines Ketamine analogs 12 portable urinals distributed accross Central London 1 sample per urinal, once a month for 6 consecutive months NPS Frequency of detection (n. of months) Mephedrone 6 Methylhexanamine (DMAA) Methiopropamine (MPA) 5 Pipradrol 4 Cathinone 5-(2-aminopropyl)benzofuran (5-APB) 3 4-methylethcathinone (4-MEC)

NPS in Pooled Urine Synth. cathinones Synth. cannabinoids Phenethylamines Piperazines Ketamine analogs 4 portable urinals in central locations within 9 UK cities 1 sample per urinal after a 12-h period on a Saturday night in April 2014 NPS Frequency of detection (n. of cities) Mephedrone 5 Methiopropamine (MPA) 3 Methylhexanamine (DMAA) 2 Methoxetamine (MXE) 3-trifluoromethylphenylpiperazine (TFMPP) 1 Benzylpiperazine (BZP) Pentedrone Methylone Glaucine

NPS in Wastewater

NPS in Wastewater

NPS in Wastewater

2 weeks/month in May&Nov 2012 <LOQ-2 mg/day/1000 inh (1 city) NPS in Wastewater Compound Australia UK Finland Belgium& Switzerland Italy Adelaida Cambridge 10 cities 9 cities 6 cities 17 cities 6-8 weeks/year over 2009-2011 3 days 2 weeks/month in May&Nov 2012 8 days in August 2012 some days in 2013, 2 weeks in 2014 7 days/year over 2010-2013 Methcathinone 11-23 mg/w/1000 inh 253 µg/L Mephedrone <LOQ-15 mg/w/1000 inh 549 µg/L 1-24 ng/L (2 cities) Methylone <LOQ-22 mg/w/1000 inh traces occasionally n.d.-2 ng/L Ethylone <LOQ (3 cities) Butylone 3 µg/L <LOQ (2 cities) MDPV <LOQ-9 mg/w/1000 inh 1-20 mg/day/1000 inh (2 cities) <LOQ-2 mg/day/1000 inh (1 city) BZP <LOQ-275 mg/w/1000 inh TFMPP 1-30 mg/w/1000 inh 4-FPP 98 µg/L MBZP 6 µg/L 4-MEOPP 8 µg/L MXE n.d.-12 ng/L PMMA

5 WWTPs in Santorini Island JWH-018 N-5-hydroxypentyl NPS in Wastewater Compound Norway Greece Oslo, Hamar, Bergen 5 WWTPs in Santorini Island 3 days in July 2012 7 days in July 2013 JWH-018 N-5-hydroxypentyl 49-62 mg/day/1000 inh JWH-122 <LOQ n.d.-4 ng/L JWH-210 CP47, 497 <LOQ-305 ng/L α-PVP n.d.-7 ng/L Synth. cathinones Synth. cannabinoids Phenethylamines Piperazines Ketamine analogs 7 Synthetic cathinones 3 Synthetic cannabinoids + 1 metabolite 5 Piperazines 1 Phenethylamine 1 Ketamine analog 4 Synthetic cathinones No Synthetic cannabinoids detected!! 2 Piperazines 3 Phenethylamines 1 Ketamine analog 4 Other substances

THANK YOU FOR YOUR ATTENTION